scispace - formally typeset
G

Gianluca Petris

Researcher at University of Trento

Publications -  32
Citations -  925

Gianluca Petris is an academic researcher from University of Trento. The author has contributed to research in topics: Endoplasmic reticulum & Genome editing. The author has an hindex of 12, co-authored 25 publications receiving 582 citations. Previous affiliations of Gianluca Petris include Laboratory of Molecular Biology & International Centre for Genetic Engineering and Biotechnology.

Papers
More filters
Journal ArticleDOI

A highly specific SpCas9 variant is identified by in vivo screening in yeast.

TL;DR: A yeast-based assay to identify optimized Streptococcus pyogenes Cas9 (SpCas9) variants that enables simultaneous evaluation of on- and off-target activity is developed and evoCas9, a variant that has fidelity exceeding both wild-type and rationally designed Cas9 variants, is generated.
Journal ArticleDOI

Hit and go CAS9 delivered through a lentiviral based self-limiting circuit

TL;DR: A Self-Limiting Cas9 circuit for Enhanced Safety and specificity (SLiCES) which consists of an expression unit for Streptococcus pyogenes Cas9, a self-targeting sgRNA and a second sg RNA targeting a chosen genomic locus results in increased genome editing specificity by controlling Cas9 levels.
Journal ArticleDOI

VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9.

TL;DR: The authors developed vesicles (VEsiCas) carrying CRISPR-SpCas9 ribonucleoprotein complexes (RNPs) that are efficiently delivered into target cells through the fusogenic glycoprotein of the vesicular stomatitis virus (VSV-G).
Journal ArticleDOI

Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing.

TL;DR: A gene therapy approach using the programmable nuclease AsCas12a to correct a splicing mutation in CFTR, and show efficient repair of the mutation and recovery of CFTR function in patient-derived organoids and airway epithelial cells.
Journal ArticleDOI

Tobacco Etch Virus protease: A shortcut across biotechnologies

TL;DR: TEVp is a unique endopeptidase largely exploited in biotechnology from industrial applications to in vitro and in vivo cellular studies, and some of its multiple applications are described.